Skip to Content

Investor Relations

BioScrip, Inc. is the largest independent national provider of infusion and home care management solutions, with approximately 2,100 teammates and nearly 70 service locations across the U.S...
Read More

Corporate Profile

BioScrip, Inc. is the largest independent national provider of infusion and home care management solutions, with approximately 2,100 teammates and nearly 70 service locations across the U.S. BioScrip partners with physicians, hospital systems, payors, pharmaceutical manufacturers and skilled nursing facilities to provide patients access to post-acute care services. BioScrip operates with a commitment to bring customer-focused pharmacy and related healthcare infusion therapy services into the home or alternate-site setting. By collaborating with the full spectrum of healthcare professionals and the patient, BioScrip provides cost-effective care that is driven by clinical excellence, customer service, and values that promote positive outcomes and an enhanced quality of life for those it serves.

Investor Overview

News Releases

Date Title and Summary
Toggle Summary BioScrip to Present at the Bank of America Merrill Lynch 2018 Leveraged Finance Conference
DENVER , Nov. 20, 2018 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that Daniel E. Greenleaf , President and Chief Executive Officer, and Stephen M.
Toggle Summary BioScrip Reports Third Quarter 2018 Financial Results
DENVER , Nov. 06, 2018 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced its third quarter 2018 financial results.                                               
Toggle Summary BioScrip Comments on Implementation of Medicare Home Infusion Transition Benefit
-- Reaffirming Guidance for 2019 Adjusted EBITDA of at least $75 million -- DENVER , Nov. 01, 2018 (GLOBE NEWSWIRE) --   BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that the